Literature DB >> 22867268

Chemical synthesis and immunological evaluation of the inner core oligosaccharide of Francisella tularensis.

Thomas J Boltje1, Wei Zhong, Jin Park, Margreet A Wolfert, Wangxue Chen, Geert-Jan Boons.   

Abstract

Francisella tularensis, which is a Gram negative bacterium that causes tularemia, has been classified by the Center for Disease Control and Prevention (CDC) as a category A bioweapon. The development of vaccines, immunotherapeutics, and diagnostics for F. tularensis requires a detailed knowledge of the saccharide structures that can be recognized by protective antibodies. We have synthesized the inner core region of the lipopolysaccharide (LPS) of F. tularensis to probe antigenic responses elicited by a live and subunit vaccine. The successful preparation of the target compound relied on the use of a disaccharide which was modified by the orthogonal protecting groups diethylisopropylsilyl (DEIPS), 2-naphthylmethyl (Nap), allyl ether (All), and levulinoyl (Lev) ester. The ability to remove the protecting groups in different orders made it possible to establish the optimal glycosylations sequence to prepare a highly crowded 1,2,3-cis configured branching point. A variety of different methods were exploited to control anomeric selectivities of the glycosylations. A comparison of the (1)H NMR spectra of isolated material and the synthetic derivative confirmed the reported structural assignment of the inner core oligosaccharide of F. tularensis . The observation that immunizations with LPS lead to antibody responses to the inner core saccharides provides an impetus to further explore this compound as a vaccine candidate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22867268      PMCID: PMC3458509          DOI: 10.1021/ja306274v

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  27 in total

1.  Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4.

Authors:  Stephen H Gregory; Wilbur H Chen; Stephanie Mott; John E Palardy; Nicholas A Parejo; Sara Heninger; Christine A Anderson; Andrew W Artenstein; Steven M Opal; Alan S Cross
Journal:  Vaccine       Date:  2010-02-17       Impact factor: 3.641

2.  Structural analysis of Francisella tularensis lipopolysaccharide.

Authors:  Evgeny Vinogradov; Malcolm B Perry; J Wayne Conlan
Journal:  Eur J Biochem       Date:  2002-12

3.  Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen.

Authors:  J Wayne Conlan; Hua Shen; Ann Webb; Malcolm B Perry
Journal:  Vaccine       Date:  2002-10-04       Impact factor: 3.641

4.  Stereoelectronic effects determine oxacarbenium vs β-sulfonium ion mediated glycosylations.

Authors:  Thomas J Boltje; Jin-Hwan Kim; Jin Park; Geert-Jan Boons
Journal:  Org Lett       Date:  2010-12-15       Impact factor: 6.005

Review 5.  Tularemia vaccines: recent developments and remaining hurdles.

Authors:  J Wayne Conlan
Journal:  Future Microbiol       Date:  2011-04       Impact factor: 3.165

6.  New principles for glycoside-bond formation.

Authors:  Xiangming Zhu; Richard R Schmidt
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

7.  Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.

Authors:  Sailaja Arungundram; Kanar Al-Mafraji; Jinkeng Asong; Franklin E Leach; I Jonathan Amster; Andre Venot; Jeremy E Turnbull; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

8.  Chiral-auxiliary-mediated 1,2-cis-glycosylations for the solid-supported synthesis of a biologically important branched alpha-glucan.

Authors:  Thomas J Boltje; Jin-Hwan Kim; Jin Park; Geert-Jan Boons
Journal:  Nat Chem       Date:  2010-05-23       Impact factor: 24.427

9.  Structure of the O-antigen of Francisella tularensis strain 15.

Authors:  E V Vinogradov; A S Shashkov; Y A Knirel; N K Kochetkov; N V Tochtamysheva; S F Averin; O V Goncharova; V S Khlebnikov
Journal:  Carbohydr Res       Date:  1991-07-30       Impact factor: 2.104

Review 10.  Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research.

Authors:  Thomas J Boltje; Therese Buskas; Geert-Jan Boons
Journal:  Nat Chem       Date:  2009-11       Impact factor: 24.427

View more
  15 in total

1.  Antibacterials: A sweet vaccine.

Authors:  David Bundle
Journal:  Nat Chem       Date:  2016-03       Impact factor: 24.427

2.  An antibacterial vaccination strategy based on a glycoconjugate containing the core lipopolysaccharide tetrasaccharide Hep2Kdo2.

Authors:  Lingbing Kong; Balakumar Vijayakrishnan; Michael Kowarik; Jin Park; Alexandra N Zakharova; Larissa Neiwert; Amirreza Faridmoayer; Benjamin G Davis
Journal:  Nat Chem       Date:  2016-02-01       Impact factor: 24.427

3.  Enzymatic synthesis of 3-deoxy-d-manno-octulosonic acid (KDO) and its application for LPS assembly.

Authors:  Liuqing Wen; Yuan Zheng; Tiehai Li; Peng George Wang
Journal:  Bioorg Med Chem Lett       Date:  2016-04-21       Impact factor: 2.823

4.  Chemical synthesis of the outer core oligosaccharide of Escherichia coli R3 and immunological evaluation.

Authors:  Wenjing Shang; Zhongying Xiao; Zaikuan Yu; Na Wei; Guohui Zhao; Qing Zhang; Mohui Wei; Xuan Wang; Peng George Wang; Tiehai Li
Journal:  Org Biomol Chem       Date:  2015-03-12       Impact factor: 3.876

5.  Assembly of a Complex Branched Oligosaccharide by Combining Fluorous-Supported Synthesis and Stereoselective Glycosylations using Anomeric Sulfonium Ions.

Authors:  Wei Huang; Qi Gao; Geert-Jan Boons
Journal:  Chemistry       Date:  2015-08-06       Impact factor: 5.236

Review 6.  The atypical lipopolysaccharide of Francisella.

Authors:  Nihal A Okan; Dennis L Kasper
Journal:  Carbohydr Res       Date:  2013-07-02       Impact factor: 2.104

7.  Synthesis of chlamydia lipopolysaccharide haptens through the use of α-specific 3-iodo-Kdo fluoride glycosyl donors.

Authors:  Barbara Pokorny; Paul Kosma
Journal:  Chemistry       Date:  2014-10-29       Impact factor: 5.236

8.  Development of αGlcN(1↔1)αMan-based lipid A mimetics as a novel class of potent Toll-like receptor 4 agonists.

Authors:  Florian Adanitsch; Simon Ittig; Johannes Stöckl; Alja Oblak; Mira Haegman; Roman Jerala; Rudi Beyaert; Paul Kosma; Alla Zamyatina
Journal:  J Med Chem       Date:  2014-09-25       Impact factor: 7.446

9.  Synthetically defined glycoprotein vaccines: current status and future directions.

Authors:  Roberto Adamo; Alberto Nilo; Bastien Castagner; Omar Boutureira; Francesco Berti; Gonçalo J L Bernardes
Journal:  Chem Sci       Date:  2013-05-16       Impact factor: 9.825

10.  First and stereoselective synthesis of an α-(2→5)-linked disaccharide of 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo).

Authors:  Barbara Pokorny; Paul Kosma
Journal:  Org Lett       Date:  2014-12-12       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.